Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy
- PMID: 32048067
- DOI: 10.1007/s11912-020-0891-2
Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy
Abstract
Purpose of review: Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of cancer treatment, with conventional treatment limited in its ability for prevention or treatment of symptoms. This review addresses the research assessing the effectiveness and safety of complementary and integrative medicine (CIM) in preventing and treating CIPN-related symptoms.
Recent findings: The CIM modalities acupuncture, classical massage, omega-3 fatty acids, and the Japanese Kampo medicine Goshanjishen may be of benefit in preventing or treating CIPN. Vitamin E (alpha-tocopherol), glutamine/glutamate, alpha-lipoic acid, and acetyl-L-carnitine (ALCAR) are not, with ALCAR increasing symptom severity and vitamin E the risk for developing prostate cancer. CIM therapies with a potential for preventing or treating CIPN-related symptoms should be further investigated. CIM is considered safe when provided within an integrative oncology setting, under the guidance and supervision of an integrative physician.
Keywords: Acupuncture; Chemotherapy-induced neuropathy; Complementary and integrative medicine; Dietary supplements; Touch therapies.
Similar articles
-
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.Crit Rev Oncol Hematol. 2016 Feb;98:325-34. doi: 10.1016/j.critrevonc.2015.11.014. Epub 2015 Nov 23. Crit Rev Oncol Hematol. 2016. PMID: 26652982 Free PMC article.
-
A Narrative Review of Complementary Nutritional Supplements for Chemotherapy-induced Peripheral Neuropathy.Altern Ther Health Med. 2020 Jul;26(4):43-49. Altern Ther Health Med. 2020. PMID: 31634876 Review.
-
Impact of acupuncture and integrative therapies on chemotherapy-induced peripheral neuropathy: A multicentered, randomized controlled trial.Cancer. 2022 Oct;128(20):3641-3652. doi: 10.1002/cncr.34422. Epub 2022 Aug 12. Cancer. 2022. PMID: 35960141 Clinical Trial.
-
Exploring an Integrative Patient-Tailored Complementary Medicine Approach for Chemotherapy-Induced Taste Disorders.Explore (NY). 2018 Jul-Aug;14(4):289-294. doi: 10.1016/j.explore.2017.09.012. Epub 2018 Apr 22. Explore (NY). 2018. PMID: 29785939
-
Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy.J Integr Med. 2017 Mar;15(2):77-87. doi: 10.1016/S2095-4964(17)60313-3. J Integr Med. 2017. PMID: 28285612 Review.
Cited by
-
Acupuncture-related interventions improve chemotherapy-induced peripheral neuropathy: A systematic review and network meta-analysis.BMC Complement Med Ther. 2024 Aug 19;24(1):310. doi: 10.1186/s12906-024-04603-1. BMC Complement Med Ther. 2024. PMID: 39160496 Free PMC article.
-
Selection of sciatic nerve injury models: implications for pathogenesis and treatment.Front Neurol. 2025 May 7;16:1521941. doi: 10.3389/fneur.2025.1521941. eCollection 2025. Front Neurol. 2025. PMID: 40401028 Free PMC article. Review.
-
Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis.Front Pharmacol. 2021 May 13;12:684550. doi: 10.3389/fphar.2021.684550. eCollection 2021. Front Pharmacol. 2021. PMID: 34054560 Free PMC article. Review.
-
Chemotherapy-induced polyneuropathy in cancer care-the patient perspective.Support Care Cancer. 2023 Mar 27;31(4):235. doi: 10.1007/s00520-023-07688-5. Support Care Cancer. 2023. PMID: 36971861 Free PMC article.
-
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.Support Care Cancer. 2023 Oct 17;31(12):637. doi: 10.1007/s00520-023-08082-x. Support Care Cancer. 2023. PMID: 37847317 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials